Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Advanced Course on Precision Oncology in Breast Cancer 2023: Barcelona

Session 2 – Molecular Targets in ER+ Disease – PIK3CA and AKT Pathway

Value/Health Economics of Testing and Targeting (Incl. MCBS, ESCAT Actionability, RWD) for ESR1, PIK3CA and AKT

Date

09 Jun 2023

Session

Session 2 – Molecular Targets in ER+ Disease – PIK3CA and AKT Pathway

Topics

Cancer Care Equity Principles and Health Economics;  Genetic and Genomic Testing;  Targeted Therapy

Tumour Site

Breast Cancer

Presenters

D. Trapani, IT

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.